Carlos Cruchaga

What is the relationship between COVID-19 and Alzheimer’s disease?

Is there a genetic basis for the rate of progression of Alzheimer’s disease?

Deep molecular profiling to identify new genetic variants and drug targets in Alzheimer’s disease

Combining genetics and molecular biomarkers for Alzheimer’s disease prognostication

Disparate roles of activated microglia across the Alzheimer’s spectrum

Projects of the Alzheimer’s Functional Genomics Consortium: iPSC modelling and multi-omics

The Alzheimer’s Disease Sequencing Project Functional Genomics Consortium